---
figid: PMC3720596__oncotarget-04-494-g001
figlink: /pmc/articles/PMC3720596/figure/F1/
number: F1
caption: 'Wild type NRAS (top left) cycles between an inactive GDP-bound and active
  GTP-bound state, whereas mutations in G12, G13 and Q61 prevent hydrolysis of GTP,
  locking mutant NRAS in its GTP-bound, active state (top right) which results in
  permanent, stimulus independent downstream signaling. NRAS-GTP activates downstream
  effectors of the MAPK and PI3K/mTOR pathway (dark blue boxes). Schematic of the
  cell cycle pathway (light blue) and interaction sites of the specific inhibitors
  in the different cascades (red lines). (RTK: receptor tyrosine kinases, GAP: GAPase
  activating protein, GEF: guanosine exchange factor, MEKi: MEK inhibitor, PI3K/mTORi:
  PI3K/mTOR inhibitor, CDKi4,6: CDK4,6 inhibitor)'
pmcid: PMC3720596
papertitle: NRAS mutant melanoma – undrugable?.
reftext: Christian Posch, et al. Oncotarget. 2013 Apr;4(4):494-495.
pmc_ranked_result_index: '17169'
pathway_score: 0.9596441
filename: oncotarget-04-494-g001.jpg
figtitle: NRAS mutant melanoma – undrugable?
year: '2013'
organisms:
- Mus musculus
- Rattus norvegicus
- Homo sapiens
ndex: dc1472a5-ded1-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3720596__oncotarget-04-494-g001.html
  '@type': Dataset
  description: 'Wild type NRAS (top left) cycles between an inactive GDP-bound and
    active GTP-bound state, whereas mutations in G12, G13 and Q61 prevent hydrolysis
    of GTP, locking mutant NRAS in its GTP-bound, active state (top right) which results
    in permanent, stimulus independent downstream signaling. NRAS-GTP activates downstream
    effectors of the MAPK and PI3K/mTOR pathway (dark blue boxes). Schematic of the
    cell cycle pathway (light blue) and interaction sites of the specific inhibitors
    in the different cascades (red lines). (RTK: receptor tyrosine kinases, GAP: GAPase
    activating protein, GEF: guanosine exchange factor, MEKi: MEK inhibitor, PI3K/mTORi:
    PI3K/mTOR inhibitor, CDKi4,6: CDK4,6 inhibitor)'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - PIK3R3
  - E2F5
  - PIK3CG
  - E2F3
  - PIK3CB
  - E2F2
  - E2F4
  - MAPK1
  - AKT3
  - ARAF
  - PIK3CD
  - NRAS
  - E2F1
  - E2F6
  - PRKCA
  - PIK3CA
  - SLC2A4RG
  - MTOR
  - E2F8
  - PIK3R6
  - PIK3R4
  - RASA1
  - E2F7
  - RAF1
  - MAPK3
  - MAP2K2
  - CDKN2A
  - CCND1
  - PIK3R5
  - MAP2K1
  - AKT2
  - CDK4
  - BRAF
  - AKT1
  - Cancer
  - Lung cancer
genes:
- word: PI3K/MTORI
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: E2F
  symbol: E2F
  source: bioentities_symbol
  hgnc_symbol: E2F5
  entrez: '1875'
- word: PI3K/MTORI
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: E2F
  symbol: E2F
  source: bioentities_symbol
  hgnc_symbol: E2F3
  entrez: '1871'
- word: PI3K/MTORI
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: E2F
  symbol: E2F
  source: bioentities_symbol
  hgnc_symbol: E2F2
  entrez: '1870'
- word: E2F
  symbol: E2F
  source: bioentities_symbol
  hgnc_symbol: E2F4
  entrez: '1874'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: ARAF
  entrez: '369'
- word: PI3K/MTORI
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: NRAS
  symbol: NRAS
  source: hgnc_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: E2F
  symbol: E2F
  source: bioentities_symbol
  hgnc_symbol: E2F1
  entrez: '1869'
- word: E2F
  symbol: E2F
  source: bioentities_symbol
  hgnc_symbol: E2F6
  entrez: '1876'
- word: PKCa
  symbol: PKCA
  source: hgnc_prev_symbol
  hgnc_symbol: PRKCA
  entrez: '5578'
- word: PI3K/MTORI
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: GEF
  symbol: GEF
  source: hgnc_alias_symbol
  hgnc_symbol: SLC2A4RG
  entrez: '56731'
- word: 'MTOR:'
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: E2F
  symbol: E2F
  source: bioentities_symbol
  hgnc_symbol: E2F8
  entrez: '79733'
- word: PI3K/MTORI
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: PI3K/MTORI
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: GAP
  symbol: GAP
  source: hgnc_alias_symbol
  hgnc_symbol: RASA1
  entrez: '5921'
- word: E2F
  symbol: E2F
  source: bioentities_symbol
  hgnc_symbol: E2F7
  entrez: '144455'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: CDKN2A
  symbol: CDKN2A
  source: hgnc_symbol
  hgnc_symbol: CDKN2A
  entrez: '1029'
- word: CyclinD1
  symbol: Cyclin-D1
  source: bioentities_symbol
  hgnc_symbol: CCND1
  entrez: '595'
- word: PI3K/MTORI
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: CDK4
  symbol: CDK4
  source: hgnc_symbol
  hgnc_symbol: CDK4
  entrez: '1019'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
chemicals: []
diseases:
- word: Cancer
  source: ''
  identifier: ''
- word: Lung cancer
  source: ''
  identifier: ''
figid_alias: PMC3720596__F1
redirect_from: /figures/PMC3720596__F1
figtype: Figure
---
